• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Cedars-Sinai Launches AI-Powered VR Therapy App on Apple Vision Pro

by Fred Pennic 02/02/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Xaia, Cedars-Sinai’s eXtended-Reality Artificially Intelligent Ally, is now available on Apple Vision Pro. Image by Cedars-Sinai.

What You Should Know:

– Cedars-Sinai clinicians have teamed up with AI experts to develop an AI-powered VR therapy app, Xaia, that leverages the power of Apple Vision Pro to offer an immersive, accessible approach to mental health support.

– By harnessing the power of AI and virtual reality, the app offers a convenient, engaging, and effective way for individuals to manage their mental well-being. As technology continues to evolve, apps like Xaia hold immense potential to democratize access to quality care and empower individuals to prioritize their mental health.

AI Meets Virtual Reality

Xaia offers patients a self-administered, AI-driven therapy experience within the calming environment of virtual reality. Imagine yourself in a serene meadow by a babbling brook or on a sun-drenched beach, guided by a friendly AI avatar trained to mimic a human therapist. This immersive setting allows users to engage in deep breathing exercises, meditation, and personalized conversations designed to address their mental health needs.

From Research to Reality: A Transformative Step

Dr. Omer Liran, a psychiatrist at Cedars-Sinai and co-founder of Xaia, emphasizes the app’s potential to revolutionize mental health accessibility: “Xaia represents a transformative step in making quality therapy accessible to all.”

The app’s development is backed by extensive research. A groundbreaking study published in Nature Digital Medicine demonstrated the app’s effectiveness and safety for patient use. This research, coupled with Cedars-Sinai’s Technology Ventures program, paved the way for bringing Xaia to life.

While Xaia is not intended to replace traditional therapy, it has the potential to reach individuals who might otherwise struggle to access mental healthcare.

“Apple Vision Pro offers a gateway into Xaia’s world of immersive, interactive behavioral health support—making strides that I can only describe as a quantum leap beyond previous technologies,” said Brennan Spiegel, MD, MSHS, professor of Medicine, director of Health Services Research at Cedars-Sinai and co-founder of the Xaia technology. “With Xaia and the stunning display in Apple Vision Pro, we are able to leverage every pixel of that remarkable resolution and the full spectrum of vivid colors to craft a form of immersive therapy that’s engaging and deeply personal.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: apple, Artificial Intelligence, Behavioral Health, Mental Health, Therapeutic Virtual Reality, Virtual Reality

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |